top of page
![QOL Med - legacy logo 2019_100c70m40k[1][1].png](https://static.wixstatic.com/media/8b0a43_beca4abfaf6b4fb6b931b4c2cfc4097a~mv2.png/v1/crop/x_0,y_119,w_1224,h_538/fill/w_424,h_186,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/QOL%20Med%20-%20legacy%20logo%202019_100c70m40k%5B1%5D%5B1%5D.png)
ABOUT US
QOL Medical, LLC is a patient-centric company with a focus on the acquisition and commercialization of orphan drug therapies in underserved markets. QOL Medical’s goal is to expand clinical awareness and patient access to help make a difference in people's lives in the treatment of orphan diseases. QOL Medical currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (ethanolamine oleate) Injection 5%.
Tony Rantisi
Representative
bottom of page